China Universal Asset Management Co., Ltd. 2seventy Bio, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 21, 2024	BUY	$3.14 - $11.2 $2,015 - $7,190	642 Added 97.57%	1,300 $5,000
Q3 2023 Oct 30, 2023	BUY	$3.14 - $11.2 $2,015 - $7,190	642 Added 97.57%	1,300 $5,000
Q2 2023 May 21, 2024	BUY	$8.45 - $12.48 $1,225 - $1,809	145 Added 28.27%	658 $6,000
Q2 2023 Jul 27, 2023	BUY	$8.45 - $12.48 $1,225 - $1,809	145 Added 28.27%	658 $7,000
Q1 2023 May 21, 2024	BUY	$9.21 - $14.98 $1,169 - $1,902	127 Added 32.9%	513 $5,000
Q1 2023 Apr 27, 2023	BUY	$9.21 - $14.98 $1,169 - $1,902	127 Added 32.9%	513 $5,000
Q4 2022 May 21, 2024	BUY	$8.57 - $17.0 $3,308 - $6,562	386 New	386 $3,000
Q4 2022 Jan 31, 2023	BUY	$8.57 - $17.0 $3,308 - $6,562	386 New	386 $4,000

Others Institutions Holding TSVT

# of Institutions

126

Shares Held

45.6M

Call Options Held

122K

Put Options Held

19.8K

Kynam Capital Management, LP Princeton, NJ

5.95M
Shares

$23.6 Million
2.31% of portfolio
Goldman Sachs Group Inc New York, NY

4.22M
Shares

$16.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.77M
Shares

$14.9 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.66M
Shares

$14.5 Million
0.0% of portfolio
Morgan Stanley New York, NY

2.89M
Shares

$11.5 Million
0.0% of portfolio

View Full List

About 2seventy bio, Inc.

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $150M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

More about TSVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account